- $954.80m
- $1.19bn
- $756.99m
- 83
- 51
- 97
- 91
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 721 | 629 | 645 | 713 | 757 |
Cost of Revenue | |||||
Gross Profit | 152 | 138 | 142 | 145 | 164 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 665 | 583 | 597 | 668 | 728 |
Operating Profit | 56.1 | 45.5 | 48.9 | 44.9 | 28.9 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 37.8 | 32 | 170 | 33.3 | 16.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 32.5 | 29.2 | 136 | 28.8 | 15.9 |
Net Income Before Extraordinary Items | |||||
Net Income | 32.5 | 29.2 | 136 | 28.8 | 15.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 32.5 | 29.2 | 136 | 28.8 | 15.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.77 | 2.69 | 2.52 | 2.77 | 2.31 |